EntryPoint Capital, LLC
- SEC CIK
- 0001992519
- Latest filing
- Aug 13, 2026
TBPH holding history
Theravance Biopharma, Inc. in every 13F filed by EntryPoint Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TBPH overviewAll 13F holders of TBPHFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −49,739−100.0% | Sold out | Holders |
| Q1 2026 | 49,739 | $807.3K | 0.2% | +15,164+43.9% | Added | Holders |
| Q4 2025 | 34,575 | $646.9K | 0.3% | +4,320+14.3% | Added | Holders |
| Q3 2025 | 30,255 | $441.7K | 0.2% | +2,351+8.4% | Added | Holders |
| Q2 2025 | 27,904 | $307.8K | 0.2% | +27,904 | New | Holders |